English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine MedTech
青岛国资+双管线驱动!华芢生物(02396.HK)破局PDGF稀缺赛道 锚定国配核心机遇
Dec 16, 2025 10:39 HKT
青島國資+雙管線驅動!華芢生物(02396.HK)破局PDGF稀缺賽道 錨定國配核心機遇
Dec 16, 2025 10:39 HKT
康哲藥業(867.HK/8A8.SG):創新藥口服JAK1抑制劑Povorcitinib在中國獲納入「突破性治療品種」
Dec 16, 2025 08:07 HKT
康哲药业(867.HK/8A8.SG):创新药口服JAK1抑制剂Povorcitinib在中国获纳入"突破性治疗品种"
Dec 16, 2025 08:06 HKT
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China
Dec 15, 2025 21:00 HKT
国资护航+技术壁垒+优质保荐 华芢生物(02396.HK)PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT
國資護航+技術壁壘+優質保薦 華芢生物(02396.HK)PDGF管線直指18A賽道確定性價值
Dec 15, 2025 09:28 HKT
康哲藥業(0867)抗急性缺血性卒中創新藥注射用Y-3中國NDA獲受理
Dec 11, 2025 20:01 HKT
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT
康哲药业(0867)抗急性缺血性卒中创新药注射用Y-3中国NDA获受理
Dec 11, 2025 19:53 HKT
拨康视云股价飙升逾8成 多重利好催化迎价值重估
Dec 11, 2025 08:20 HKT
撥康視雲股價飆升逾8成 多重利好催化迎價值重估
Dec 11, 2025 08:20 HKT
AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation
Dec 02, 2025 12:22 HKT
卓智医院与香港养和医院携手推出优质跨境医疗礼宾服务
Nov 17, 2025 16:54 HKT
卓智醫院與香港養和醫院攜手推出優質跨境醫療禮賓服務
Nov 17, 2025 16:54 HKT
'iRad Hospital' and 'Hong Kong Sanatorium & Hospital' Partner to Launch Premium Cross-Border Medical Concierge Services
Nov 17, 2025 16:54 HKT
康诺思腾(Cornerstone Robotics)完成新一轮约2亿美元超募融资
Nov 13, 2025 20:38 HKT
Cornerstone Robotics Closes Oversubscribed New Financing Round of Approximately US$200 million
Nov 11, 2025 11:38 HKT
康諾思騰(Cornerstone Robotics)完成新一輪約2億美元超募融資
Nov 10, 2025 08:46 HKT
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 20:00 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: